Center for Biological Diversity v. U.S. Intl. Dev. Finance Corp, No. 22-5095 (D.C. Cir. 2023)
Annotate this Case
The Sunshine Act’s “agency” definition only encompasses those with a majority of Board members whom the President appoints and the Senate confirms to such position. Government in the Sunshine Act (Sunshine Act). For years, the Center for Biological Diversity, Friends of the Earth, and the Center for International Environmental Law (collectively, CBD) enjoyed the benefits from the Sunshine Act’s application to the Overseas Private Investment Corporation (OPIC). By statute, it reorganized OPIC into the International Development Finance Corporation (DFC). Congress shrunk DFC’s Board of Directors (the Board) from fifteen members to nine. DFC’s Chief Executive Officer (CEO) serves by virtue of their appointment to DFC instead of to the Board itself. Thus, DFC thought its Board majority was composed only of ex officio members. Accordingly, it promulgated a rule exempting itself from the Sunshine Act without notice-and-comment. CBD sued. The district court granted DFC’s motion to dismiss.
The DC Circuit affirmed. The court held that CBD clearly had informational standing because the information it statutorily sought is from the agency itself. Next, the court held that the Sunshine Act does not apply to DFC because a majority of its Board members serves ex officio by virtue of their appointments to other positions. Finally, the court held that CBD’s claim that DFC violated the Administrative Procedure Act (APA) by not engaging in notice-and-comment rulemaking fails because CBD did not demonstrate any prejudice arising from the asserted APA violation distinct from the legal question of Sunshine Act compliance.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.